Perspective
- Yes, Patients Are Getting More Complicated
49
- Experiencing the Evolution of Early NSCLC Treatment
- Early NSCLC: Three Forms That Contribute to Failure to Diagnose
- Cannabis for Psychiatric Disorders? Experts Weigh In
30
- Study Identifies CV Comorbidities Linked to Dermatomyositis
- New Tool May Offer Diagnostic Edge for Diabetic Neuropathy
- Medscape Medical Minute
- Intermittent Energy Restriction Tied to Gut, Brain Changes
18
- Gastric Cancer Survival Differs by Race and Ethnicity
- Targeting IDH Mutated Glioma: A Decade’s Journey from Bench to Bedside.
- Medicare Bundled Payment Model Fails to Boost HF Outcomes
- Intensive Weight Loss Does Not Ease Gout Symptoms
1
- Navigating the Paradigm Shift: A New Era of Glioma Care.
- The Microbiome: It's What's Inside That Counts
3
- Healthcare Violence: Docs Bear Brunt of Business Pressures
11
- Jan 05 2024 This Week in Cardiology
4
- Do Statins Offset Venous Thrombosis Risk With Hormone Therapy?
12
- Magnetic Seeds/Guidewires for Breast Cancer Localization?
- Impact of Pregnancy on Rosacea Unpredictable, Study Suggests
- A Snapshot of Ulcerative Colitis: Part I
- Mortality Still Significant in High-Risk PE Despite Advances
1
- Long-term Clopidogrel Has Advantages After Coronary Stenting
2
- Changes in the Treatment Landscape of Early-Stage Non-Small Cell Lung Cancer
- Top Studies in Neurology From 2023
- US Dermatologic Drug Approvals Rose Between 2012 and 2022
- Prior Auth Tied to Delays, Discontinuation of Cancer Meds
1
- 5 Things to Know About Antifungal Therapeutic Drug Monitoring
- Is It Time to Air Grievances?
2
- Mechanisms of Hypothalamic Inflammation in Obesity
- Circadian BP Shifts Earlier in Children With MS OSA
- Optimal Follow-up After Cervical Cancer Surgery
- Artificial Sweeteners Alter the Duodenal Microbiome
27
- Myelofibrosis Highlights From ASH 2023
- Clinical Takeaways in Thrombocytopenia From ASH 2023
- New Research Points to a Better Biomarker for MSI mCRC
- An Alternative to Walking Out
38
- Supercharge Your Medical Practice With ChatGPT
- Antiobesity Drugs in OA: Slow, Moderate Approach Deemed Best
- Wide Regional Variation in Diagnosis of Long COVID
5
- Mass Shooters and Mental Illness: Reexamining the Connection
45